| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | See Remarks
2 companies
Turtle Cameron is a Chief Executive Officer at Spyre Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 25 sells.
Estimated insider holdings value: $55.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | SYRE Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $70.43 | $1,056,486.02 | -0.8% | - | - | |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $71.37 | $1,070,507.00 | -0.4% | - | - | |
| Apr 1, 2026 | SYRE Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $49.33 | $739,912.32 | -1.2% | - | - | |
| Feb 2, 2026 | SYRE Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $32.80 | $492,045.15 | -1.1% | +112.0% | - | |
| Jan 2, 2026 | SYRE Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $30.68 | $460,134.12 | -0.7% | +59.9% | - | |
| Dec 1, 2025 | SYRE Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 15,000 | $29.02 | $435,355.50 | -1.1% | +48.2% | - | |
| Nov 3, 2025 | SYRE Spyre Therapeutics, Inc. | Chief Executive Officer | Sell | 45,000 | $23.33 | $1,049,777.85 | -3.1% | +37.7% | - | |
| Dec 28, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 19,500 | $69.60 | $1,357,184.04 | -36.7% | - | - | |
| Nov 25, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 5,000 | $47.04 | $235,180.84 | -16.6% | - | - | |
| Nov 5, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 2,500 | $42.05 | $105,124.75 | -16.6% | - | - |